| 000 | 01637 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250518032829.0 | ||
| 264 | 0 | _c20200220 | |
| 008 | 202002s 0 0 eng d | ||
| 022 | _a1432-2277 | ||
| 024 | 7 |
_a10.1111/tri.13436 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBöhmig, Georg A | |
| 245 | 0 | 0 |
_aThe therapeutic challenge of late antibody-mediated kidney allograft rejection. _h[electronic resource] |
| 260 |
_bTransplant international : official journal of the European Society for Organ Transplantation _cAug 2019 |
||
| 300 |
_a775-788 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAllografts _ximmunology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aBortezomib _xtherapeutic use |
| 650 | 0 | 4 |
_aGraft Rejection _ximmunology |
| 650 | 0 | 4 |
_aGraft Survival _xdrug effects |
| 650 | 0 | 4 | _aHistocompatibility |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xtherapeutic use |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aIsoantibodies _xblood |
| 650 | 0 | 4 | _aKidney Transplantation |
| 650 | 0 | 4 | _aProteasome Inhibitors |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aRituximab _xtherapeutic use |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 700 | 1 | _aEskandary, Farsad | |
| 700 | 1 | _aDoberer, Konstantin | |
| 700 | 1 | _aHalloran, Philip F | |
| 773 | 0 |
_tTransplant international : official journal of the European Society for Organ Transplantation _gvol. 32 _gno. 8 _gp. 775-788 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/tri.13436 _zAvailable from publisher's website |
| 999 |
_c29559565 _d29559565 |
||